Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Squamous Cell Carcinoma of Head and Neck × Quality of Life × 1 year × Clear all

Sponsor

Conditions

Neoplasms 3 Sarcoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Thymus Neoplasms 1 Sex Cord-Gonadal Stromal Tumors 1 Sarcoma, Synovial 1 Peritoneal Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mesothelioma 1 Meningioma 1 Lymphoma, Large B-Cell, Diffuse 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Fatigue 1 Dermatofibrosarcoma 1 Cardiovascular Diseases 1 Carcinoma, Squamous Cell 1 Brain Neoplasms 1 Bone Neoplasms 1

Interventions

pembrolizumab 119 Cisplatin 70 Cetuximab 52 Carboplatin 46 Nivolumab 39 Paclitaxel 38 Docetaxel 33 Radiotherapy 32 Radiotherapy, Intensity-Modulated 23 Fluorouracil 19 Magnetic Resonance Spectroscopy 18 Specimen Handling 16 Taxes 11 durvalumab 10 cemiplimab 10 Radiation 10 Platinum 10 Ipilimumab 10 1,2-diaminocyclohexaneplatinum II citrate 10 atezolizumab 9 Drug Therapy 9 Albumin-Bound Paclitaxel 9 tislelizumab 8 Surgical Procedures, Operative 7 Standard of Care 7 Chemoradiotherapy 7 Biopsy 7 130-nm albumin-bound paclitaxel 7 toripalimab 6 avelumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡